Biogen Inc.
BIIB
$130.60
$1.160.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 240.50M | 266.70M | 388.50M | 583.60M | 393.40M |
| Total Depreciation and Amortization | 183.20M | 184.00M | 182.80M | 158.90M | 147.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 169.10M | 281.90M | 130.50M | 71.90M | 241.00M |
| Change in Net Operating Assets | -333.50M | 28.30M | 233.80M | -188.60M | -228.70M |
| Cash from Operations | 259.30M | 760.90M | 935.60M | 625.80M | 553.20M |
| Capital Expenditure | -37.10M | -39.30M | -35.00M | -33.50M | -45.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | -1.07B | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.20M | 20.70M | -71.30M | 500.00M | -20.10M |
| Cash from Investing | -47.30M | -18.60M | -1.18B | 466.50M | -66.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -250.00M | -400.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -23.00M | 7.90M | -6.60M | 4.80M | -39.60M |
| Cash from Financing | -23.00M | 7.90M | -6.60M | -245.20M | -439.60M |
| Foreign Exchange rate Adjustments | 34.30M | -74.40M | 42.40M | -12.60M | -23.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 223.30M | 675.80M | -209.70M | 834.50M | 24.50M |